{ "cik": 1582313, "cik_padded": "0001582313", "entityName": "Xenon Pharmaceuticals Inc.", "fiscal_years": [ { "accn": "0001193125-26-076650", "filed": "2026-02-26", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 799000.0, "cash": 199163000.0, "eps_diluted": -4.36, "free_cash_flow": -279917000.0, "net_income": -345910000.0, "operating_cash_flow": -279118000.0, "operating_income": -373070000.0, "revenue": 7500000.0, "stockholders_equity": 581760000.0, "total_assets": 633163000.0, "total_liabilities": 51403000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.08835774202420242, "roa_avg2y": -0.4833501245718933, "roa_period_end": -0.5463206157024336, "roe_avg2y": -0.5175724920941179, "roe_period_end": -0.5945922717271728 } }, { "accn": "0001193125-26-076650", "filed": "2026-02-26", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3075000.0, "cash": 142712000.0, "eps_diluted": -3.01, "free_cash_flow": -184464000.0, "net_income": -234330000.0, "operating_cash_flow": -181389000.0, "operating_income": -279298000.0, "stockholders_equity": 754903000.0, "total_assets": 798139000.0, "total_liabilities": 43236000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.05727358349350844, "roa_avg2y": -0.26584046962540353, "roa_period_end": -0.293595476477155, "roe_avg2y": -0.27849614695297903, "roe_period_end": -0.3104107415124857 } }, { "accn": "0001193125-26-076650", "filed": "2026-02-26", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 5617000.0, "cash": 148643000.0, "eps_diluted": -2.73, "free_cash_flow": -156729000.0, "net_income": -182393000.0, "operating_cash_flow": -151112000.0, "operating_income": -214054000.0, "stockholders_equity": 927921000.0, "total_assets": 964798000.0, "total_liabilities": 36877000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.03974152972074131, "roa_avg2y": -0.21221517396727294, "roa_period_end": -0.18904786286870412, "roe_avg2y": -0.22116043355898868, "roe_period_end": -0.19656091412954335 } }, { "accn": "0001193125-26-076650", "filed": "2026-02-26", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2894000.0, "cash": 57242000.0, "eps_diluted": -2.06, "free_cash_flow": -103922000.0, "net_income": -125373000.0, "operating_cash_flow": -101028000.0, "operating_income": -129143000.0, "revenue": 9434000.0, "stockholders_equity": 721497000.0, "total_assets": 754146000.0, "total_liabilities": 32649000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.045251747408513135, "revenue_growth_yoy": -0.4883115474317948, "roa_avg2y": -0.1890777308500603, "roa_period_end": -0.16624499765297437, "roe_avg2y": -0.19720022335296847, "roe_period_end": -0.17376787429469562 } }, { "accn": "0000950170-25-029149", "filed": "2025-02-27", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2050000.0, "cash": 175688000.0, "eps_diluted": -1.77, "free_cash_flow": -71552000.0, "net_income": -78882000.0, "operating_cash_flow": -69502000.0, "operating_income": -78993000.0, "revenue": 18437000.0, "stockholders_equity": 550033000.0, "total_assets": 572007000.0, "total_liabilities": 21974000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.0399503302529121, "revenue_growth_yoy": -0.4268171361064478, "roa_avg2y": -0.2072588686443517, "roa_period_end": -0.1379039067703717, "roe_avg2y": -0.21869507116835876, "roe_period_end": -0.14341321338901483 } }, { "accn": "0001564590-22-008060", "filed": "2024-02-29", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2637000.0, "cash": 45009000.0, "eps_diluted": -0.81, "free_cash_flow": -50761000.0, "net_income": -28837000.0, "operating_cash_flow": -48124000.0, "operating_income": -31301000.0, "revenue": 32166000.0, "stockholders_equity": 171355000.0, "total_assets": 189186000.0, "total_liabilities": 17831000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.10405882524583467, "net_margin": -0.8965056270596282, "operating_margin": -0.9731082509482062, "revenue_growth_yoy": 3.7102064723971298, "roa_avg2y": -0.17119890288319684, "roa_period_end": -0.15242671233600796, "roe_avg2y": -0.21901629881670287, "roe_period_end": -0.1682880569577777 } }, { "accn": "0001564590-21-009905", "filed": "2023-03-01", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1240000.0, "cash": 24755000.0, "free_cash_flow": -5954000.0, "net_income": -41595000.0, "operating_cash_flow": -4714000.0, "operating_income": -42819000.0, "revenue": 6829000.0, "stockholders_equity": 91977000.0, "total_assets": 147697000.0, "total_liabilities": 55720000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.6058036248192483, "roa_avg2y": -0.307968533086534, "roa_period_end": -0.28162386507512, "roe_avg2y": -0.4260211397435372, "roe_period_end": -0.4522326233732346 } }, { "accn": "0001564590-21-009905", "filed": "2021-03-01", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 507000.0, "cash": 67754000.0, "eps_diluted": -1.63, "free_cash_flow": -35231000.0, "net_income": -34497000.0, "operating_cash_flow": -34724000.0, "operating_income": -38040000.0, "stockholders_equity": 103295000.0, "total_assets": 122428000.0, "total_liabilities": 19133000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.18522677767558934, "roa_avg2y": -0.40934090383212, "roa_period_end": -0.2817737772405005, "roe_avg2y": -0.49554331353381836, "roe_period_end": -0.3339658260322378 } }, { "accn": "0001564590-20-009385", "filed": "2020-03-09", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 315000.0, "cash": 20486000.0, "eps_diluted": -1.72, "free_cash_flow": -29041000.0, "net_income": -30704000.0, "operating_cash_flow": -28726000.0, "operating_income": -32575000.0, "stockholders_equity": 35934000.0, "total_assets": 46121000.0, "total_liabilities": 10187000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2834919574775978, "roa_avg2y": -0.5405253151186536, "roa_period_end": -0.6657271091259946, "roe_avg2y": -0.6150949065958832, "roe_period_end": -0.8544553904380252 } }, { "accn": "0001564590-19-006514", "filed": "2019-03-06", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 279000.0, "cash": 17095000.0, "eps_diluted": -1.48, "net_income": -22997000.0, "operating_income": -24817000.0, "stockholders_equity": 63901000.0, "total_assets": 67487000.0, "total_liabilities": 3586000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.05611805762038153, "roa_period_end": -0.3407619245187962, "roe_period_end": -0.3598848218337741 } }, { "accn": "0001564590-18-004750", "filed": "2018-03-07", "fiscal_year": 2015, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares" }, "fundamentals": { "eps_diluted": -1.1 }, "period_end": "2015-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001193125-26-076650", "filed": "2026-02-26", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001582313.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001582313.json" }, "ticker": "XENE" }